AI empowers early lung cancer screening, diagnosis and treatment upgrades, domestic medical robots accelerate the implementation of precision medicine, real health care (02697) welcomes industry development opportunities

The Zhitong Finance App learned that with the continuous integration of cutting-edge technologies such as artificial intelligence and medical robots into clinical diagnosis and treatment, early screening and accurate diagnosis and treatment of lung cancer are ushering in new breakthroughs. Recently, the First Affiliated Hospital of Guangzhou University of Traditional Chinese Medicine introduced an artificial intelligence thoracic surgery robot to accurately locate small lung nodules through AI to upgrade from traditional “blind investigation” to “precise sniper”, greatly improving the efficiency of early lung cancer diagnosis and treatment, and bringing patients more accurate and minimally invasive treatment plans.

According to the data, lung cancer is still one of the malignant tumors with the highest incidence rate and mortality rate in China, but if it can be detected and treated at an early stage, the survival rate of patients can be significantly improved. Traditional lung nodule positioning relies on repeated CT scans, which not only takes a long time, but also has positioning errors. AI navigation combined with robot-assisted technology can achieve single accurate positioning, shorten surgery time, reduce trauma, and preserve healthy lung tissue to the greatest extent, providing a new technical path for early diagnosis and treatment of lung cancer.

Industry insiders believe that as technologies such as AI image recognition, 3D reconstruction, and robot-assisted intervention continue to mature, the medical robot industry is accelerating into the commercial application stage, covering many high-value tracks such as lung cancer, orthopedics, and neurosurgery, and the industry has broad room for growth.

Benefiting from the trend of medical intelligence upgrading, True Health Care (02697), the “first stock of puncture surgery robots”, continues to promote the layout of artificial intelligence and digital medical care. The company continues to improve product systems in fields such as smart medicine, AI-assisted diagnosis and treatment, and medical informatization, and actively promotes the application of artificial intelligence technology in hospital clinical scenarios. As the country continues to promote the digitalization of medical care and the accelerated implementation of new technologies such as AI medical robots and accurate diagnosis and treatment, True Health Care is expected to benefit from an increase in industry prosperity and further open up room for long-term growth.